Welcome to our dedicated page for DaVita news (Ticker: DVA), a resource for investors and traders seeking the latest updates and insights on DaVita stock.
DaVita Inc. (NYSE: DVA) is a leading health care provider focused on transforming care delivery to improve the quality of life for patients globally. With over 20 years of clinical quality and innovation, DaVita is one of the largest providers of kidney care services in the United States. The company operates more than 3,000 dialysis centers globally, serving approximately 250,200 patients, with 2,675 centers in the U.S. and 367 in 11 other countries.
Core Business: DaVita specializes in treating patients with chronic kidney failure and end-stage renal disease. The company provides comprehensive kidney care services, including dialysis treatments, integrated treatment plans, personalized care teams, and convenient health-management services to enhance patients' quality of life.
Recent Achievements: In recent quarters, DaVita has focused on innovation and operational improvements. The company has introduced the Center Without Walls™ (CWOW) platform in collaboration with Google Cloud, leveraging AI and analytics to enhance clinical outcomes. Furthermore, DaVita has integrated its clinical systems to streamline care for its 201,300 patients in the U.S. alone.
Financial Highlights: DaVita reported strong financial performance in 2023, with quarterly and annual growth driven by increased dialysis treatments and improved reimbursement rates. The company has also actively engaged in share repurchases, further solidifying its financial stability.
Partnerships and Projects: DaVita has expanded its international footprint, recently announcing acquisitions in Brazil, Colombia, Chile, and Ecuador. These strategic investments align with DaVita's disciplined growth strategy and aim to enhance its presence in Latin America. Additionally, DaVita has partnered with the American Diabetes Association to tackle chronic disease prevention, particularly focusing on diabetes and kidney disease.
Commitment to Community: DaVita is deeply committed to community well-being, as evidenced by initiatives like the annual Move It With Purpose event, which raised significant funds for the Bridge of Life nonprofit. This event supports global efforts to prevent and treat chronic diseases in underserved communities.
DaVita’s forward-looking initiatives, including investments in integrated kidney care and advanced clinical systems, position the company for sustainable growth and leadership in the health care sector.
DaVita announced record-breaking participation in its third annual Move It With Purpose (MIWP) event, with over 8,300 participants logging 550,000 miles of activity across nearly 150 events nationwide. The month-long initiative raised more than $750,000 for Bridge of Life, DaVita's nonprofit organization focused on global chronic disease prevention and treatment.
Since 2007, DaVita's fundraising events have generated over $15 million for Bridge of Life, which has reached 34 countries and impacted nearly 150,000 lives through its 3,000 volunteers. The organization provides screenings, medications, and education in countries including Bangladesh, Belize, Guatemala, South Africa, and Vietnam.
DaVita Inc. (NYSE: DVA) announced its participation in the UBS Global Healthcare Conference 2024 on November 12, 2024. CFO Joel Ackerman and Group VP of Investor Relations Nic Eliason will engage in a fireside chat at 12:30 pm PST.
DaVita is a leading kidney care provider serving 265,400 patients across 3,113 outpatient dialysis centers globally, with 2,660 centers in the United States and 453 centers in 13 other countries as of September 30, 2024. The company specializes in comprehensive kidney care services, from disease progression management to transplantation support and home dialysis, maintaining a 20-year track record of clinical excellence and innovation.
DaVita Inc. (DVA) reported strong financial results for Q3 2024. The company achieved consolidated revenues of $3.264 billion and operating income of $535 million. Diluted earnings per share reached $2.50, while adjusted diluted EPS was $2.59. Operating cash flow was $810 million with free cash flow of $555 million.
The company repurchased 2.7 million shares at an average price of $147.20 per share. DaVita secured new financing through a $1.1 billion Term Loan A-1 and issued $1.0 billion in senior notes. U.S. dialysis metrics showed 7,350,784 total treatments, with revenue per treatment increasing to $394.49.
DaVita Giving Foundation announced an investment in the National Kidney Foundation's PEERS program, which provides social and emotional support for patients, care partners, and living donors through mentor connections. The program currently has over 356 participants as mentors and mentees, with 81% managing chronic illnesses like kidney failure.
The initiative aims to address mental health challenges in chronic disease care, as patients with chronic conditions are more likely to experience depression. The program facilitates telephone-based connections between participants, allowing them to discuss their kidney care journey with others who have similar experiences.
DaVita Clinical Research (DCR) will present five research projects at ASN's Kidney Week 2024 in San Diego. The research focuses on improving racial equity in transplantation and clinical quality measures. Studies examine topics including: the impact of nephrologist visits on hospitalization rates, racial disparities in transplant processes among Hispanic dialysis patients, effects of heavy precipitation on dialysis treatment attendance, early indicators of ESKD transition in AKI-dialysis patients, and blood pressure thresholds in CKD patients. The presentations aim to enhance upstream CKD care management and promote health equity.
DaVita announced performance year one clinical outcomes achieved through value-based care arrangements with nearly 1,300 nephrologists across the U.S. These efforts are part of the Comprehensive Kidney Care Contracting (CKCC) option within the government's voluntary Kidney Care Choices (KCC) model, which began on Jan. 1, 2022.
Key achievements include:
- 16% industry increase in optimal start rates for kidney patients transitioning to dialysis
- Embedding care team members in 68% of nephrology practices
- Overseeing approximately 31,000 patients across multiple care settings
- 2.4x more DaVita patients having a planned start on home treatment
- 67% of patients screened for depression remission
- 13% increase in patient activation
DaVita's tech-enabled platform and increased CKD education efforts have contributed to these improvements. The company expects continued progress in outcomes and cost savings as the CKCC program evolves.
DaVita, a leading kidney care services provider, has appointed Jessica Hergenreter as its new chief people officer (CPO). Hergenreter will lead the People Services team, overseeing initiatives to engage and support DaVita's 70,000+ global employees. The company was recently recognized as a Top Workplace by USA Today and one of America's Most Loved Companies by Newsweek.
Hergenreter brings 13 years of experience from Vail Resorts, where she held various leadership roles and most recently led talent strategies for 55,000 employees. Her focus areas included talent acquisition, development, and fostering diversity and inclusion. DaVita's CEO, Javier Rodriguez, expressed enthusiasm about Hergenreter's appointment, citing her fresh energy and innovative ideas to drive initiatives for attracting and retaining top talent.
DaVita Kidney Care has opened its dialysis centers in Florida to anyone needing treatment following Hurricane Milton, including patients from other providers. Patients can call DaVita Guest Services at 1-800-400-8331 for help locating centers and scheduling treatment. Approximately 50,000 Floridians with kidney failure currently receive dialysis treatment.
DaVita activated its emergency response plan before the hurricane, proactively dialyzing thousands of patients in over 150 centers. The company has deployed water tankers, fuel tankers, generators, supplies, and medication across Florida to ensure centers can treat patients in impacted areas as soon as possible. DaVita's national emergency management team is supporting affected centers and routing patients to safe locations for care.
DaVita Inc. (NYSE: DVA) has announced its upcoming third quarter 2024 investor conference call, scheduled for Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close on the same day. Investors can access the call via webcast or by dialing in, with the password "Earnings" required.
DaVita, a comprehensive kidney care provider, serves approximately 265,100 patients at 3,124 outpatient dialysis centers globally as of June 30, 2024. The company operates 2,672 centers in the United States and 452 centers across 13 other countries. DaVita focuses on transforming care delivery to improve patients' quality of life, offering services from slowing kidney disease progression to supporting transplantation and providing dialysis at home.
DaVita Kidney Care has activated its emergency response plan in preparation for Hurricane Milton's landfall in Florida. The company is proactively dialyzing thousands of patients ahead of the storm in over 150 centers. DaVita's priorities are safety and continuity of care for approximately 50,000 Floridians who receive dialysis treatment.
Local teammates are providing patients with medical information and evacuation details. DaVita is coordinating with other healthcare providers to ensure continuity of care and will track patient transfers. Patients and families can visit DaVita's newsroom for center closure updates or call DaVita Guest Services for assistance.
The company emphasizes the importance of emergency preparedness for kidney patients, recommending an emergency kit with essential items such as medication, medical supplies, and emergency contact information.
FAQ
What is the current stock price of DaVita (DVA)?
What is the market cap of DaVita (DVA)?
What is DaVita Inc. specialized in?
How many dialysis centers does DaVita operate?
What recent technological advancements has DaVita made?
What are DaVita’s recent achievements?
How does DaVita support its community?
Who are DaVita’s key partners?
What financial results did DaVita report in 2023?
What is DaVita's strategy for international growth?
What does DaVita’s expansion in Latin America entail?
How does DaVita enhance patient care?
